Barclays downgraded Givaudan (GVDNY) to Equal Weight from Overweight with a price target of CHF 3,050, down from CHF 3,550. The firm says a “renewed spike” in costs from the Middle East conflict reopens the pricing cycle for European consumer ingredients. Volumes, not costs, are the bigger concern, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GVDNY:
- Givaudan downgraded to Hold from Buy at Deutsche Bank
- Givaudan price target lowered to CHF 2,875 from CHF 3,000 at Morgan Stanley
- Givaudan price target lowered to CHF 3,150 from CHF 3,350 at Citi
- Givaudan downgraded to Sell from Buy at Goldman Sachs
- Givaudan price target lowered to CHF 3,350 from CHF 3,500 at Citi
